PubMed:25537159 8 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 135-162 | DP | denotes | HER2-positive breast cancer |
| T24 | 226-231 | DP | denotes | LA BC |
| T25 | 247-263 | DP | denotes | HER2-positive BC |
| T1 | 290-301 | CI | denotes | Trastuzumab |
| T2 | 306-316 | CI | denotes | pertuzumab |
| T3 | 582-590 | CI | denotes | afatinib |
| T4 | 599-610 | CI | denotes | trastuzumab |
| T5 | 614-623 | CI | denotes | lapatinib |
| T27 | 656-676 | DP | denotes | HER2-positive, LA BC |
| T28 | 717-742 | DP | denotes | HER2-positive BC patients |
| T6 | 820-828 | CI | denotes | afatinib |
| T7 | 838-847 | CI | denotes | lapatinib |
| T8 | 869-880 | CI | denotes | trastuzumab |
| T9 | 1212-1220 | CI | denotes | afatinib |
| T10 | 1231-1240 | CI | denotes | lapatinib |
| T11 | 1253-1264 | CI | denotes | trastuzumab |
| T12 | 1308-1316 | CI | denotes | afatinib |
| T13 | 1321-1330 | CI | denotes | lapatinib |
| T14 | 1339-1350 | CI | denotes | trastuzumab |
| T15 | 1423-1432 | CI | denotes | lapatinib |
| T16 | 1440-1451 | CI | denotes | trastuzumab |
| T17 | 1500-1508 | CI | denotes | afatinib |
| T18 | 1638-1647 | CI | denotes | lapatinib |
| T19 | 1681-1692 | CI | denotes | trastuzumab |
| T20 | 1749-1757 | CI | denotes | Afatinib |
| T21 | 1816-1827 | CI | denotes | trastuzumab |
| T22 | 1832-1841 | CI | denotes | lapatinib |
| T29 | 1871-1887 | DP | denotes | HER2-positive BC |